Lineage Cell Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of LCTX for the last quarter is 1.44 M USD, and it's 30.84% lower compared to the previous quarter. The net income of Q1 24 is -6.54 M USD.